Gut Microbiota is Altered in Patients with Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 63, Issue 4, 2018, Pages 1337-1346

  Zhuang, Zhen Qian ^a   Shen, Lin Lin ^a   Li, Wei Wei ^a   Fu, Xue ^b   Zeng, Fan ^a   Gui, Li ^c   Lü, Yang ^b   Cai, Min ^d   Zhu, Chi ^a   Tan, Yin Ling ^c   Zheng, Peng ^b   Li, Hui Yun ^a   Zhu, Jie ^a   Zhou, Hua Dong ^a   Bu, Xian Le ^a   Wang, Yan Jiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d Chongqing Yuzhong Psychiatric Hospital   (China)

Author keywords

16S ribosomal RNA sequencing; Alzheimer's disease; amyloid peptide; gut microbiota

Indexed keywords

RNA 16S;

ACTINOBACTERIA; AGED; ALZHEIMER DISEASE; ARTICLE; BACTEROIDES; BACTEROIDETES; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRMICUTES; HUMAN; INTESTINE FLORA; LACHNOSPIRACEAE; MALE; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; RUMINOCOCCUS; SELENOMONADALES; SEQUENCE ANALYSIS; VERRUCOMICROBIA; CASE CONTROL STUDY; FECES; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RNA, RIBOSOMAL, 16S;

EID: 85048627786     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-180176     Document Type: Article

References (45)

1. Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer's disease. Nat Rev Dis Primers 1, 15056.
2. Lim SL, Rodriguez-Ortiz CJ, KitazawaM (2015) Infection, systemic inflammation, and Alzheimer's disease. Microbes Infect 17, 549-556.
3. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
4. Klein HU, Bennett DA, De Jager PL (2016) The epigenome in Alzheimer's disease: Current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol 132, 503-514.
5. Parashar A, UdayabanuM (2017) Gut microbiota: Implications in Parkinson's disease. Parkinsonism Relat Disord 38, 1-7.
6. Jin Y, Wu S, Zeng Z, Fu Z (2017) Effects of environmental pollutants on gut microbiota. Environ Pollut 222, 1-9.
7. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC (2017) Microbes and mental health: A review. Brain Behav Immun 66, 9-17.
8. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, Zhang X, Yang D, Yang Y, Meng H, Li W, Melgiri ND, Licinio J, Wei H, Xie P (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry 21, 786-796.
9. Ahmad K (2013) Identification of common target proteins for multiple neurodegenerative disorders and reconstruction of disease pathway. Physical Review B 67, 1393-1406.
10. Wang JY, Zhou DH, Li J, Zhang M, Deng J, Tang M, Gao C, Li J, LianY, ChenM (2006) Leisure activity and risk of cognitive impairment: The Chongqing aging study. Neurology 66, 911-913.
11. Li J,Wang YJ, Zhang M, Xu ZQ, GaoCY, Fang CQ,Yan JC, Zhou HD, Chongqing Ageing Study Group (2011) Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 76, 1485-1491.
12. Bu XL, Yao XQ, Jiao SS, Zeng F, Liu YH, Xiang Y, Liang CR,Wang QH,Wang X, CaoHY,YiX, Deng B, Liu CH, Xu J, Zhang LL, Gao CY, Xu ZQ, Zhang M, Wang L, Tan XL, Xu X, Zhou HD,Wang YJ (2015) Astudy on the association between infectious burden and Alzheimer's disease. Eur J Neurol 22, 1519-1525.
13. Adetutu EM, Thorpe K, Bourne S, Cao X, Shahsavari E, Kirby G, Ball AS (2011) Phylogenetic diversity of fungal communities in areas accessible and not accessible to tourists in Naracoorte Caves. Mycologia 103, 959-968.
14. AnderssonAF, LindbergM, Jakobsson H, Backhed F, Nyren P, Engstrand L (2008) Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 3, e2836.
15. Hou YP, He QQ, Ouyang HM, Peng HS, Wang Q, Li J, Lv XF, Zheng YN, Li SC, Liu HL, Yin AH (2017) Human gut microbiota associated with obesity in Chinese children and adolescents. Biomed Res Int 2017, 7585989.
16. Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S (2016) From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol Psychiatry 21, 738-748.
17. Cryan JF, Dinan TG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13, 701-712.
18. Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20, 145-155.
19. Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, Xie P, Morrison M, Wesselingh SL, Rogers GB, Licinio J (2016) Inflammasome signaling affects anxiety-and depressive-like behavior and gut microbiome composition. Mol Psychiatry 21, 797-805.
20. Distrutti E, O'Reilly JA, McDonald C, Cipriani S, Renga B, Lynch MA, Fiorucci S (2014) Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS One 9, e106503.
21. Arentsen T, Qian Y, Gkotzis S, Femenia T, Wang T, Udekwu K, ForssbergH, Diaz Heijtz R (2017) The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol Psychiatry 22, 257-266.
22. Savignac HM, Tramullas M, Kiely B, Dinan TG, Cryan JF (2015) Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res 287, 59-72.
23. Zhang L, Wang Y, Xiayu X, Shi C, Chen W, Song N, Fu X, Zhou R, Xu YF, Huang L, Zhu H, Han Y, Qin C (2017) Altered gut microbiota in a mouse model of Alzheimer's disease. J Alzheimers Dis 60, 1241-1257.
24. Vogt NM,Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, BlennowK, Bendlin BB, Rey FE (2017) Gut microbiome alterations in Alzheimer's disease. Sci Rep 7, 13537.
25. Wang QH, Wang X, Bu XL, Lian Y, Xiang Y, Luo HB, Zou HQ, Pu J, Zhou ZH, Cui XP, Wang QS, Shi XQ, Han W, Wu Q, Chen HS, Lin H, Gao CY, Zhang LL, Xu ZQ, Zhang M, Zhou HD, Wang YJ (2017) Comorbidity burden of dementia: A hospital-based retrospective study from 2003 to 2012 in seven cities in China. Neurosci Bull 33, 703-710.
26. Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB, Group I-F (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49, 60-68.
27. Polk BF, Kasper DL (1977) Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med 86, 569-571.
28. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463.
29. Hynonen U, Rasinkangas P, Satokari R, Paulin L, de Vos WM, Pietila TE, Kant R, Palva A (2016) Isolation and whole genome sequencing of a Ruminococcus-like bacterium, associated with irritable bowel syndrome. Anaerobe 39, 60-67.
30. Zhan X, Stamova B, Jin LW, DeCarli C, Phinney B, Sharp FR (2016) Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87, 2324-2332.
31. Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ (2017) 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer's post-mortem brain. Front Aging Neurosci 9, 195.
32. Lukiw WJ (2016) Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease. Front Microbiol 7, 1544.
33. Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, Chang EB, Tanzi RE, Sisodia SS (2016) Antibioticinduced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci Rep 6, 30028.
34. Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, Oyler-Castrillo P, Zhang X, Musch MW, Shen X, Jabri B, Chang EB, Tanzi RE, Sisodia SS (2017) Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1DeltaE9 murine model of Alzheimer's disease. Sci Rep 7, 10411.
35. Wang XL, Zeng J, Feng J, Tian YT, Liu YJ, Qiu M, Yan X, Yang Y, Xiong Y, Zhang ZH, Wang Q, Wang JZ, Liu R (2014) Helicobacter pylori filtrate impairs spatial learning and memory in rats and increases beta-amyloid by enhancing expression of presenilin-2. Front Aging Neurosci 6, 66.
36. Wang XL, Zeng J, Yang Y, Xiong Y, Zhang ZH, Qiu M, Yan X, Sun XY, Tuo QZ, Liu R, Wang JZ (2015) Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3beta. J Alzheimers Dis 43, 153-165.
37. Hu X, Wang T, Jin F (2016) Alzheimer's disease and gut microbiota. Sci China Life Sci 59, 1006-1023.
38. Alkasir R, Li J, Li X, Jin M, Zhu B (2017) Human gut microbiota: The links with dementia development. Protein Cell 8, 90-102.
39. Mudd AT, Berding K, Wang M, Donovan SM, Dilger RN (2017) Serum cortisol mediates the relationship between fecal Ruminococcus and brain N-acetylaspartate in the young pig. Gut Microbes 8, 589-600.
40. Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B (2012) Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res 9, 5-17.
41. Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hultgren SJ (2002) Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851-855.
42. Zhao Y, Dua P, Lukiw WJ (2015) Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer's Didease (AD). J Alzheimers Dis Parkinsonism 5, 177.
43. Bu XL, Xiang Y, Jin WS, Wang J, Shen LL, Huang ZL, Zhang K, Liu YH, Zeng F, Liu JH, Sun HL, Zhuang ZQ, Chen SH, Yao XQ, Giunta B, Shan YC, Tan J, Chen XW, Dong ZF, Zhou HD, Zhou XF, Song W, Wang YJ (2017) Blood-derived amyloid-beta protein induces Alzheimer's disease pathologies. Mol Psychiatry, doi: 10. 1038/mp. 2017. 204
44. Wang J, Gu BJ, Masters CL, Wang YJ (2017) A systemic view of Alzheimer disease-insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol 13, 612-623.
45. Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG (2018) Does Parkinson's disease start in the gut? Acta Neuropathol 135, 1-12.